Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

40.620
-3.580-8.10%
Volume:18.78M
Turnover:777.40M
Market Cap:23.64B
PE:-9.07
High:44.500
Open:43.560
Low:40.260
Close:44.200
52wk High:80.900
52wk Low:29.980
Shares:582.00M
HK Float Shares:582.00M
Volume Ratio:1.02
T/O Rate:3.23%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-11.83%
PB:6.67
PE(LYR):-9.07
PS:53.61

Loading ...

Insilico Medicine Cayman Topco - Takeda Granted Exclusive Worldwide Rights to Develop and Commercialize Collaboration Therapeutics

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco - Deal Value up to Usd600 Mln Including USD60 Mln in Upfront and Near-term Payments

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco - Voluntary Announcement Insilico Medicine and Takeda Achieved Strategic Ai-powered Drug Discovery Collaboration Worth up to Usd600 Mln

THOMSON REUTERS
·
Jul 02

Takeda Will be Granted Exclusive Worldwide Rights Under Insilico Deal to Develop, Manufacture and Commercialize New Drugs - WSJ

THOMSON REUTERS
·
Jul 02

Takeda, Insilico Strike AI Drug-discovery Deal Worth up to $600.0 Million

Dow Jones
·
Jul 02

Insilico Leadership Voluntarily Extends Share Lock-Up Period

Stock News
·
Jun 30

Movement Alert|Insilico Medicine Falls 11.12% in Regular Trading, Massive Lock-up Share Expiry Triggers Concentrated Selling Pressure

Market Focus
·
Jun 30

Movement Alert|Insilico Medicine Falls 5.7% in Regular Trading, Selling Pressure Intensifies Ahead of Massive Lock-Up Expiry

Market Focus
·
Jun 29

Movement Alert|Insilico Medicine Falls 5.76% in Regular Trading, Profit-Taking Intensifies Ahead of Massive Lock-Up Expiry

Market Focus
·
Jun 26

Movement Alert|Insilico Medicine Rises 5.64% in Regular Trading, SK Biopharmaceuticals $2.5 Billion AI-Driven Collaboration Continues to Fuel Rally

Market Focus
·
Jun 25

Movement Alert|Insilico Medicine Rises 6.34% in Regular Trading, SK Biopharmaceuticals USD 2.5 Billion AI-Driven Collaboration Continues to Fuel Rally

Market Focus
·
Jun 24

Movement Alert|Insilico Medicine Rises 5.95% in Regular Trading, SK Biopharmaceuticals USD 2.5 Billion AI-Driven Collaboration Continues to Boost Sentiment

Market Focus
·
Jun 23

Hong Kong Stocks Decline on Renewed U.S.-China Friction; Shenzhen HQVT Technology Shines on Debut

MT Newswires Live
·
Jun 22

Shaers of Insilico Medicine Jump More Than 15% on SK Biopharmaceuticals Tie-up

THOMSON REUTERS
·
Jun 22

Insilico Medicine seals AI-driven neuroimmune R&D deal worth up to USD2.50 billion with SK Biopharmaceuticals

Bulletin Express
·
Jun 22

Insilico Partners with SK Biopharmaceuticals in AI-Powered Neuroscience Drug Discovery Deal Valued Up to $2.5 Billion

Stock News
·
Jun 22

BRIEF-Insilico Medicine And SK Biopharmaceuticals Collaborate On Drug Discovery For Neuroimmune Disorders

Reuters
·
Jun 22

Insilico Medicine, SK Biopharmaceuticals enter AI drug R&D collaboration worth up to USD 2.5 billion

Reuters
·
Jun 22

Insilico Medicine Cayman Topco - and SK Biopharmaceuticals Enter AI-Powered R&D Collaboration Worth up to $2.5 Bln

THOMSON REUTERS
·
Jun 22

Insilico Medicine Cayman Topco - Total Potential Deal Value Exceeds $2.5 Bln Including Milestones and Royalties

THOMSON REUTERS
·
Jun 22